Mindera Health™ Launches Pilot with National Health Insurance Company to Improve Management of Moderate-To-Severe Psoriasis Patients Through Precision Medicine
Pilot designed to use clinical utility and patient outcomes to validate cost savings and address wasted spend and net savings from “trial and error” medicine  SAN DIEGO, CA – May 3, 2022 – Mindera Health™, the developer of the groundbreaking Dermal Intelligence™ platform – the first realization of precision medicine in psoriasis, has initiated […]






